GGrantIndex
Sort

16,300 grants matching fatty liver disease

Diagnosing and monitoring NAFLD using unbound FFA profiles

$597,219
Alan Marc Kleinfeld · Ffa Sciences, Llc · R01 · FY2009 · DK

Testing the Adipose Expandability Hypothesis In Vivo During Overfeeding

$597,149
Ursula White · Lsu Pennington Biomedical Research Ctr · R01 · FY2025 · DK

Interaction between Genome and Heavy Metals in Nonalcoholic Fatty Liver Disease

$597,081
Wanqing Liu · Wayne State University · R01 · FY2024 · ES

Adiponectin in Cardiovascular Biology and Pathology

$596,865
Harvey F Lodish · Massachusetts Institute Of Technology · P01 · FY2008 · HL

Metabolic effects of non-nutritive sweeteners

$596,781
Kristina Rother · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2019 · DK

Transgenerational obesity caused by ancestral exposure to obesogens in utero: changes in germline genomic architecture, roles of gonadal somatic cells, and metabolomic analysis of sexual dimorphism

$596,380
Bruce Blumberg · University Of California-Irvine · R01 · FY2019 · ES

Improving disease subtyping and physiological characterization of adult-onset diabetes in electronic health records

$596,339
Maggie Ng · Vanderbilt University Medical Center · U01 · FY2024 · DK

Regulation of Hepatic Lipid and Glucose Metabolism by PC-TP/StarD2

$596,301
David E Cohen · Weill Medical Coll Of Cornell Univ · R37 · FY2018 · DK

Regulation of Hepatic Lipid and Glucose Metabolism by PC-TP/StarD2

$596,301
David E Cohen · Weill Medical Coll Of Cornell Univ · R37 · FY2020 · DK

Regulation of Hepatic Lipid and Glucose Metabolism by PC-TP/StarD2

$596,301
David E Cohen · Weill Medical Coll Of Cornell Univ · R37 · FY2019 · DK

The macro- and micro- anatomy and pathology of the aging kidney

$596,261
Andrew D Rule · Mayo Clinic Rochester · R01 · FY2014 · DK

Biology of the orphan receptor Rev-erb alpha

$596,099
Mitchell A. Lazar · University Of Pennsylvania · R01 · FY2017 · DK

Genetic Repair of Familial Hypercholesterolemia

$596,073
William Raymond Lagor · Baylor College Of Medicine · R01 · FY2017 · HL

Community Engagement Core

$596,070
Michele D Kipke · Children'S Hospital Of Los Angeles · P50 · FY2022 · MD

Understanding the metabolic pathology of pediatric obesity and NAFLD

$596,036
Kevin R. Short · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2022 · DK

Novel imprint control regions (ICRs) responsive to environmental exposures

$595,906
Cathrine Hoyo · North Carolina State University Raleigh · R01 · FY2024 · ES

Project 1 - Changes in Gut Microbiome and related Metabolome Across Trajectory of Alzheimer's Disease

$595,839
Rima F Kaddurah-Daouk · Duke University · U19 · FY2019 · AG

First in Human Clinical Trial of Mesenteric Visceral Lipectomy in Subjects with Type 2 Diabetes and Obesity

$595,713
Mark Andrew · Medality Medical, Llc · R44 · FY2020 · DK

First in Human Clinical Trial of Mesenteric Visceral Lipectomy in Subjects with Type 2 Diabetes and Obesity

$595,713
Mark Andrew · Medality Medical, Llc · R44 · FY2021 · DK

Role of Screening and Early Intervention in Primary Care with Low-Dose Pioglitazone for Patients with T2DM and NASH

$595,695
Kenneth Cusi · University Of Florida · R01 · FY2021 · DK

Blocking hepatocyte senescence as a novel therapeutic strategy for chronic liver diseases

$595,568
Michael Oertel · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · DK

Community Engagement Core

$595,459
Michele D Kipke · Children'S Hospital Of Los Angeles · P50 · FY2023 · MD

Metabolic Effects of Sleep Extension in People with Obesity

$595,451
Samuel Klein · Washington University · R01 · FY2019 · DK

Weight-Loss Diet Intervention on Cardiometabolic Factors of Gut Microbiota

$595,353
Lu Qi · Tulane University Of Louisiana · R01 · FY2024 · DK

Lymphatics in the liver

$595,209
Yasuko Iwakiri · Yale University · R01 · FY2025 · DK